Prescient Therapeutics Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
- |
Market Cap |
AUD16.95 M |
Shares Outstanding |
394.26 M |
Public Float |
- |
Address |
100 Albert Road South Melbourne Victoria (VIC) 3205 Australia |
Employees | - |
Website | http://www.prescienttherapeutics.com |
Updated | 07/08/2019 |
Prescient Therapeutics Ltd. is a biopharmaceutical company, which engages in the discovery and development of novel immunotherapeutic products for the treatment of chronic infectious diseases and cancer. It develops immune therapeutics based upon its Co-X-Gene and fowlpox virus delivery technologies. The company was founded May 22, 1986 and is headquartered in Perth, Australia. |